Chimie et radiopharmacie

Investigation of a new “N2S2O2 ” chelating agent with high Po(IV) affinity A. Younes, G. Montavon, S.G. Gouin, E. André-Joyaux, R. Peumery, T. Chalopin, C. Alliot, M. Mokili, J.Champion, D. Deniaud, Chem. Comm., 53, 6492-6495 (2017).

The bonding picture in hypervalent XF3 (X = Cl, Br, I, At) fluorides revisited with quantum chemical topology, M. Amaouch, D.-C. Sergentu, D. Steinmetz, R. Maurice, N. Galland, J. Pilmé, J. Comput. Chem., 38, 2753-2762 (2017)

Targeted radionuclide therapy with astatine-211: Oxidative dehalogenation of astatobenzoate conjugates, D. Teze, D.-C. Sergentu, V. Kalichuk, J. Barbet, D. Deniaud, N. Galland, R. Maurice, G.Montavon, Sci. Rep., 7, 2579 (2017)

Cyclams with Ambidentate Methylthiazolyl Pendants for Stable, Inert, and Selective Cu(II) Coordination Rodríguez-Rodríguez A.; Halime Z.; Lima L. M. P.; Beyler M.; Deniaud D.; Le Poul N.; Delgado R.; Platas-Iglesias C.; Patinec V.; Tripier R. Inorg. Chem., 2016, 55 (2), 619-632

Recent advances in cancer treatment by iron chelators Corcé V.; Gouin S.G.; Renaud S.; Gaboriau F.; Deniaud D. Bioorg. Med. Chem. Lett. 2016, 26, 251-256.

The heaviest possible ternary trihalogen species, IAtBr − , evidenced in aqueous solution: an experimental performance driven by computations, N. Guo, D.-C. Sergentu, D. Teze, J. Champion, G.Montavon, N. Galland, R. Maurice, Angew. Chem., Int. Ed., 55, 15369-15372 (2016)

Synthesis and Biological Properties of Quilamines II, New Iron Chelators with Antiproliferative Activities Corcé V.; Renaud S.; Cannie I.; Julienne K.; Gouin G.; Loréal O.; Gaboriau F.; Deniaud, D.Bioconjugate. Chem., 2014, 25 (2), 320-334.

Synthesis and characterization of a stable copper(I) complex for radiopharmaceutical applications Bodio E.; Boujtita M.; Julienne K.; Le Saec P.; Gouin S.G.; Hamon J.; Renault E.; Deniaud D.ChemPlusChem, 2014, 79, 1284-1293.